(Fox Business) Jury selection is set to begin Monday in the federal securities-fraud trial of Martin Shkreli, the former pharmaceutical executive and social-media provocateur who rose to international infamy two years ago for his decision to dramatically raise the prices of lifesaving drugs. Federal prosecutors in Brooklyn allege that Mr. Shkreli, 34 years old, committed a series of interconnected frauds, misleading investors in his hedge funds and looting a publicly traded pharmaceutical company to cover the losses when those funds foundered.
Jury Selection to Begin in Martin Shkreli Trial
This entry was posted in Syndicated. Bookmark the permalink.
